Endothelial cell surface vimentin binding peptide induces angiogenesis under hypoxic/ischemic conditions

Area of Science:

• Biomedical research
• Molecular biology
• Cardiovascular science

Background:

• Angiogenic peptides targeting cell surface proteins were previously identified using phage display.
• Vimentin, a cytoskeletal protein, was unexpectedly found on the surface of endothelial cells.

Purpose of the Study:

• To characterize the SP peptide, its binding target, and its pro-angiogenic effects.
• To evaluate the therapeutic potential of SP in a mouse model of limb ischemia.

Main Methods:

• Phage display screening to identify angiogenic peptides.
• Protein precipitation and fluorocytometry to confirm SP binding to cell surface vimentin.
• In vitro assays for endothelial cell proliferation and tube formation.
• Mouse hind limb ischemia model to assess SP's effect on blood perfusion.

Main Results:

• The 12-amino acid SP peptide specifically binds to cell surface vimentin on endothelial cells.
• SP significantly increased endothelial cell proliferation and tube formation under hypoxic conditions.
• SP administration improved blood perfusion and capillary density in ischemic mouse hind limbs.
• SP's efficacy was linked to its specific binding to vimentin.

Conclusions:

• SP peptide is a novel inducer of angiogenesis, targeting cell surface vimentin.
• SP demonstrates therapeutic potential for treating cardiovascular ischemic diseases by promoting neovascularization.